Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-03-07

Clinical Trial Update: Efficacy of CL22205 to Improve Menstrual Discomfort and Quality of Life [NA]

View source ↗

Summary

Clinical trial update for CL22205 evaluating efficacy in reducing menstrual discomfort (dysmenorrhea) and improving quality of life. The study is not yet recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CL22205

Snippet

Sponsor: Eetho Brands, Inc | Conditions: Menstrual Discomfort | NA | Status: NOT_YET_RECRUITING